TY  - JOUR
A1  - Kromer, Christian
A1  - Wellmann, Phoebe
A1  - Siemer, Ralf
A1  - Klein, Selina
A1  - Mohr, Johannes
A1  - Pinter, Andreas
A1  - Wilsmann-Theis, Dagmar Irmgard
A1  - Mößner, Rotraut
T1  - Influenza vaccination in psoriatic patients - epidemiology and patient perceptions: a german multicenter study (Vac-Pso)
T2  - Vaccines
N2  - The risk of developing severe complications from an influenza virus infection is increased in patients with chronic inflammatory diseases such as psoriasis (PsO) and atopic dermatitis (AD). However, low influenza vaccination rates have been reported. The aim of this study was to determine vaccination rates in PsO compared to AD patients and explore patient perceptions of vaccination. A multicenter cross-sectional study was performed in 327 and 98 adult patients with PsO and AD, respectively. Data on vaccination, patient and disease characteristics, comorbidity, and patient perceptions was collected with a questionnaire. Medical records and vaccination certificates were reviewed. A total of 49.8% of PsO and 32.7% of AD patients were vaccinated at some point, while in season 2018/2019, 30.9% and 13.3% received an influenza vaccination, respectively. There were 96.6% and 77.6% of PsO and AD patients who had an indication for influenza vaccination due to age, immunosuppressive therapy, comorbidity, occupation, and/or pregnancy. Multivariate regression analysis revealed higher age (p < 0.001) and a history of bronchitis (p = 0.023) as significant predictors of influenza vaccination in PsO patients. Considering that most patients had an indication for influenza vaccination, the rate of vaccinated patients was inadequately low.
KW  - psoriasis
KW  - atopic dermatitis
KW  - influenza
KW  - vaccination
KW  - pneumonia
Y1  - 2021
UR  - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/62192
UR  - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-621922
SN  - 2076-393X
N1  - This research was partially funded by a research grant from Novartis Pharma. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
VL  - 9.2021
IS  - 8, art. 843
SP  - 1
EP  - 14
PB  - MDPI
CY  - Basel
ER  -